Endocannabinoid 2-Arachidonoylglycerol Synthesis and Metabolism at Neuronal Nuclear Matrix Fractions Derived from Adult Rat Brain Cortex
暂无分享,去创建一个
M. Goicolea | G. García del Caño | X. Aretxabala | I. González-Burguera | M. López de Jesús | S. Barrondo | J. Sallés | M. Saumell-Esnaola | Imanol González-Burguera | Joan Sallés
[1] C. Ledent,et al. Fit-for-purpose based testing and validation of antibodies to amino- and carboxy-terminal domains of cannabinoid receptor 1 , 2021, Histochemistry and Cell Biology.
[2] D. Finn,et al. PPARs and pain , 2018, British journal of pharmacology.
[3] L. Marnett,et al. Aspects of Prostaglandin Glycerol Ester Biology. , 2019, Advances in experimental medicine and biology.
[4] Cheryl A. Grice,et al. Identification of ABX-1431, a Selective Inhibitor of Monoacylglycerol Lipase and Clinical Candidate for Treatment of Neurological Disorders. , 2018, Journal of medicinal chemistry.
[5] M. Duchen,et al. PPARγ as a therapeutic target to rescue mitochondrial function in neurological disease , 2016, Free radical biology & medicine.
[6] I. Galve-Roperh,et al. VCE-003.2, a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington’s disease , 2016, Scientific Reports.
[7] S. O'Sullivan,et al. An update on PPAR activation by cannabinoids , 2016, British journal of pharmacology.
[8] R. J. Barrio,et al. Nuclear diacylglycerol lipase‐α in rat brain cortical neurons: evidence of 2‐arachidonoylglycerol production in concert with phospholipase C‐β activity , 2015, Journal of neurochemistry.
[9] K. Mackie,et al. Parsing the players: 2‐arachidonoylglycerol synthesis and degradation in the CNS , 2014, British journal of pharmacology.
[10] G. García del Caño,et al. Nuclear phospholipase C-β1 and diacylglycerol LIPASE-α in brain cortical neurons. , 2014, Advances in biological regulation.
[11] Mitsuyoshi Iino,et al. Cytoplasmic localization of DGK&zgr; exerts a protective effect against p53-mediated cytotoxicity , 2013, Journal of Cell Science.
[12] K. Mackie,et al. CaMKII is a novel regulator of diacylglycerol lipase-α and striatal endocannabinoid signaling , 2013, Nature Neuroscience.
[13] J. Laitinen,et al. Biochemical and pharmacological characterization of human α/β-hydrolase domain containing 6 (ABHD6) and 12 (ABHD12)[S] , 2012, Journal of Lipid Research.
[14] I. González-Burguera,et al. Cellular neurochemical characterization and subcellular localization of phospholipase C β1 in rat brain , 2012, Neuroscience.
[15] M. Zimmermann,et al. Time-Dependent Cross Talk between Spinal Serotonin 5-HT2A Receptor and mGluR1 Subserves Spinal Hyperexcitability and Neuropathic Pain after Nerve Injury , 2012, The Journal of Neuroscience.
[16] E. Gray,et al. The PPAR-gamma agonist pioglitazone protects cortical neurons from inflammatory mediators via improvement in peroxisomal function , 2012, Journal of Neuroinflammation.
[17] B. Lutz,et al. Cannabinoid CB1 receptor activation, pharmacological blockade, or genetic ablation affects the function of the muscarinic auto- and heteroreceptor , 2012, Naunyn-Schmiedeberg's Archives of Pharmacology.
[18] Y. Surh,et al. 15-Deoxy-Δ¹²,¹⁴-prostaglandin J₂, an electrophilic lipid mediator of anti-inflammatory and pro-resolving signaling. , 2011, Biochemical pharmacology.
[19] K. Mackie,et al. COX‐2 and fatty acid amide hydrolase can regulate the time course of depolarization‐induced suppression of excitation , 2011, British journal of pharmacology.
[20] Jian Zhang,et al. Inhibition of COX‐2 expression by endocannabinoid 2‐arachidonoylglycerol is mediated via PPAR‐γ , 2011, British Journal of Pharmacology.
[21] Benjamin F. Cravatt,et al. Mechanistic and Pharmacological Characterization of PF-04457845: A Highly Potent and Selective Fatty Acid Amide Hydrolase Inhibitor That Reduces Inflammatory and Noninflammatory Pain , 2011, Journal of Pharmacology and Experimental Therapeutics.
[22] Lei Shi,et al. GABAergic disinhibition induced pain hypersensitivity by upregulating NMDA receptor functions in spinal dorsal horn , 2011, Neuropharmacology.
[23] J. V. Vanden Heuvel,et al. 15-Deoxy-Δ12,14-prostaglandin J2-Glycerol Ester, a Putative Metabolite of 2-Arachidonyl Glycerol, Activates Peroxisome Proliferator Activated Receptor γ , 2011, Molecular Pharmacology.
[24] Masahiko Watanabe,et al. Unique inhibitory synapse with particularly rich endocannabinoid signaling machinery on pyramidal neurons in basal amygdaloid nucleus , 2011, Proceedings of the National Academy of Sciences.
[25] P. Kuo,et al. Peroxisome Proliferator-activated Receptor γ Negatively Regulates IFN-β Production in Toll-like Receptor (TLR) 3- and TLR4-stimulated Macrophages by Preventing Interferon Regulatory Factor 3 Binding to the IFN-β Promoter* , 2010, The Journal of Biological Chemistry.
[26] Agnes L. Bodor,et al. The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors , 2010, Nature Neuroscience.
[27] A. Aranda-Anzaldo,et al. NeuN/Fox‐3 is an intrinsic component of the neuronal nuclear matrix , 2010, FEBS letters.
[28] L. Parsons,et al. Quantification of brain endocannabinoid levels: methods, interpretations and pitfalls , 2010, British journal of pharmacology.
[29] G. Muccioli. Endocannabinoid biosynthesis and inactivation, from simple to complex. , 2010, Drug discovery today.
[30] J. Long,et al. Blockade of 2-Arachidonoylglycerol Hydrolysis by Selective Monoacylglycerol Lipase Inhibitor 4-Nitrophenyl 4-(Dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) Enhances Retrograde Endocannabinoid Signaling , 2009, Journal of Pharmacology and Experimental Therapeutics.
[31] L. Parsons,et al. Chronic ethanol treatment potentiates ethanol‐induced increases in interstitial nucleus accumbens endocannabinoid levels in rats , 2009, Journal of neurochemistry.
[32] K. Mackie,et al. Cannabinoid signaling in inhibitory autaptic hippocampal neurons , 2009, Neuroscience.
[33] P. Castillo,et al. Endocannabinoid signaling and long-term synaptic plasticity. , 2009, Annual review of physiology.
[34] Yongnan Li,et al. Peroxisome proliferator-activated receptor gamma agonist, rosiglitazone, suppresses CD40 expression and attenuates inflammatory responses after lithium pilocarpine-induced status epilepticus in rats , 2008, International Journal of Developmental Neuroscience.
[35] M. Maccarrone,et al. FAAH and anandamide: is 2-AG really the odd one out? , 2008, Trends in pharmacological sciences.
[36] H. Bradshaw,et al. Prostaglandin E2 glycerol ester, an endogenous COX‐2 metabolite of 2‐arachidonoylglycerol, induces hyperalgesia and modulates NFκB activity , 2008, British journal of pharmacology.
[37] B. Cravatt,et al. A Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2‐Arachidonoylglycerol , 2007, Chemistry & biology.
[38] M. Maftouh,et al. CB1 receptor‐mediated control of the release of endocannabinoids (as assessed by microdialysis coupled with LC/MS) in the rat hypothalamus , 2007, The European journal of neuroscience.
[39] S. O'Sullivan,et al. Cannabinoids go nuclear: evidence for activation of peroxisome proliferator‐activated receptors , 2007, British journal of pharmacology.
[40] N. Sang,et al. COX‐2 oxidative metabolite of endocannabinoid 2‐AG enhances excitatory glutamatergic synaptic transmission and induces neurotoxicity , 2007, Journal of neurochemistry.
[41] K. Mackie,et al. A Key Role for Diacylglycerol Lipase-α in Metabotropic Glutamate Receptor-Dependent Endocannabinoid Mobilization , 2007, Molecular Pharmacology.
[42] Pedro Grandes,et al. Molecular Components and Functions of the Endocannabinoid System in Mouse Prefrontal Cortex , 2007, PloS one.
[43] B. Cravatt,et al. A functional proteomic strategy to discover inhibitors for uncharacterized hydrolases. , 2007, Journal of the American Chemical Society.
[44] L. Parsons,et al. Specific Alterations of Extracellular Endocannabinoid Levels in the Nucleus Accumbens by Ethanol, Heroin, and Cocaine Self-Administration , 2007, The Journal of Neuroscience.
[45] Masahiko Watanabe,et al. Subcellular Arrangement of Molecules for 2-Arachidonoyl-Glycerol-Mediated Retrograde Signaling and Its Physiological Contribution to Synaptic Modulation in the Striatum , 2007, The Journal of Neuroscience.
[46] M. Kano,et al. Presynaptic Monoacylglycerol Lipase Activity Determines Basal Endocannabinoid Tone and Terminates Retrograde Endocannabinoid Signaling in the Hippocampus , 2007, The Journal of Neuroscience.
[47] V. Marzo,et al. Palmitoylethanolamide, endocannabinoids and related cannabimimetic compounds in protection against tissue inflammation and pain: potential use in companion animals. , 2007, Veterinary journal.
[48] T. Freund,et al. Molecular Composition of the Endocannabinoid System at Glutamatergic Synapses , 2006, The Journal of Neuroscience.
[49] Masahiko Watanabe,et al. Localization of diacylglycerol lipase-alpha around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor. , 2006, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[50] Masahiko Watanabe,et al. Diacylglycerol kinase ζ is involved in the process of cerebral infarction , 2006 .
[51] K. Mackie,et al. Stimulation of Endocannabinoid Formation in Brain Slice Cultures through Activation of Group I Metabotropic Glutamate Receptors , 2005, Molecular Pharmacology.
[52] P. Schweitzer,et al. Inhibition of cyclooxygenase-2 elicits a CB1-mediated decrease of excitatory transmission in rat CA1 hippocampus , 2005, Neuropharmacology.
[53] A. Poso,et al. Characterization of the sulfhydryl-sensitive site in the enzyme responsible for hydrolysis of 2-arachidonoyl-glycerol in rat cerebellar membranes. , 2005, Chemistry & biology.
[54] Hee-Sup Shin,et al. Phospholipase Cβ Serves as a Coincidence Detector through Its Ca2+ Dependency for Triggering Retrograde Endocannabinoid Signal , 2005, Neuron.
[55] D. Piomelli,et al. RNA Interference Suggests a Primary Role for Monoacylglycerol Lipase in the Degradation of the Endocannabinoid 2-Arachidonoylglycerol , 2004, Molecular Pharmacology.
[56] B. Alger,et al. Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus , 2004, Nature Neuroscience.
[57] J. Laitinen,et al. Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes. , 2004, Biochemical pharmacology.
[58] A. Martelli,et al. Nuclear inositides: facts and perspectives. , 2004, Pharmacology & therapeutics.
[59] G. Baldini,et al. Diacylglycerol kinase-θ is localized in the speckle domains of the nucleus , 2003 .
[60] M. Kano,et al. Postsynaptic M1 and M3 receptors are responsible for the muscarinic enhancement of retrograde endocannabinoid signalling in the hippocampus , 2003, The European journal of neuroscience.
[61] T. Freund,et al. Role of endogenous cannabinoids in synaptic signaling. , 2003, Physiological reviews.
[62] R. Irvine. Nuclear lipid signalling , 2003, Nature Reviews Molecular Cell Biology.
[63] T. Freund,et al. A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation. , 2002, Chemistry and physics of lipids.
[64] M. Isokawa,et al. Activation of Muscarinic Acetylcholine Receptors Enhances the Release of Endogenous Cannabinoids in the Hippocampus , 2002, The Journal of Neuroscience.
[65] T. Freund,et al. Brain monoglyceride lipase participating in endocannabinoid inactivation , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[66] Rajnish A. Gupta,et al. 15-Lipoxygenase Metabolism of 2-Arachidonylglycerol , 2002, The Journal of Biological Chemistry.
[67] M. Kano,et al. Cooperative endocannabinoid production by neuronal depolarization and group I metabotropic glutamate receptor activation , 2002, The European journal of neuroscience.
[68] S. Gaetani,et al. An anorexic lipid mediator regulated by feeding , 2001, Nature.
[69] G. Schiavo,et al. Nuclear PtdIns(4,5)P2 assembles in a mitotically regulated particle involved in pre-mRNA splicing. , 2001, Journal of cell science.
[70] B. Staels,et al. Peroxisome proliferator-activated receptors in inflammation control. , 2001, The Journal of endocrinology.
[71] K. Waku,et al. Rapid generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in rat brain after decapitation , 2001, Neuroscience Letters.
[72] L. Marnett,et al. Oxygenation of the Endocannabinoid, 2-Arachidonylglycerol, to Glyceryl Prostaglandins by Cyclooxygenase-2* , 2000, The Journal of Biological Chemistry.
[73] L. Parsons,et al. Dopamine activation of endogenous cannabinoid signaling in dorsal striatum , 1999, Nature Neuroscience.
[74] M. O’Banion,et al. Cyclooxygenase-2: molecular biology, pharmacology, and neurobiology. , 1999, Critical reviews in neurobiology.
[75] L. Petrocellis,et al. Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action , 1998, Trends in Neurosciences.
[76] S. Yamamoto,et al. Anandamide amidohydrolase reacting with 2‐arachidonoylglycerol, another cannabinoid receptor ligand , 1998, FEBS letters.
[77] U. Hellman,et al. cDNA Cloning, Tissue Distribution, and Identification of the Catalytic Triad of Monoglyceride Lipase , 1997, The Journal of Biological Chemistry.
[78] D. Piomelli,et al. A second endogenous cannabinoid that modulates long-term potentiation , 1997, Nature.
[79] D. Deutsch,et al. Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidase. , 1997, Biochemical pharmacology.
[80] A. Yamashita,et al. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. , 1995, Biochemical and biophysical research communications.
[81] Z. Vogel,et al. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. , 1995, Biochemical pharmacology.
[82] D. Gibson,et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. , 1992, Science.
[83] J. Boonstra,et al. A differential location of phosphoinositide kinases, diacylglycerol kinase, and phospholipase C in the nuclear matrix. , 1992, The Journal of biological chemistry.
[84] S. Penman,et al. The nonchromatin substructures of the nucleus: the ribonucleoprotein (RNP)-containing and RNP-depleted matrices analyzed by sequential fractionation and resinless section electron microscopy , 1986, The Journal of cell biology.
[85] D. S. Coffey,et al. Considerations in the isolation of rat liver nuclear matrix, nuclear envelope, and pore complex lamina. , 1981, Experimental cell research.
[86] P. Agutter,et al. Nuclear non-chromatin proteinaceous structures: their role in the organization and function of the interphase nucleus. , 1980, Journal of cell science.
[87] R. Thompson,et al. STUDIES ON RNA SYNTHESIS IN TWO POPULATIONS OF NUCLEI FROM THE MAMMALIAN CEREBRAL CORTEX , 1973, Journal of neurochemistry.